A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy

Based on the PACIFIC study, the standard care of unresectable locally advanced non-small cell lung cancer (LA-NSCLC) shifted from concurrent chemo-radiotherapy (CCRT) alone to CCRT followed by durvalumab consolidation in 2017. In the era of immunotherapy, two kinds of therapeutic drugs are involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuyan, Chu, Xiao, Ye, Luxi, Ni, Jianjiao, Zhu, Zhengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653136/
https://www.ncbi.nlm.nih.gov/pubmed/33209628
http://dx.doi.org/10.21037/tlcr-20-512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653136/
https://www.ncbi.nlm.nih.gov/pubmed/33209628
http://dx.doi.org/10.21037/tlcr-20-512

Ejemplares similares